Extremely important negative changes in investment behavior have recently occurred for Resmed Inc (NYSE: RMD): negative upside/downside volume developed, and its shorter term price trend turned down.
Resmed Inc (NYSE: RMD). Significant negative changes in fundamentals have recently occurred: the consensus estimate for June, 2024 decreased significantly, and the consensus estimate for June, 2025 decreased significantly.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, RMD is expected to continue to be a major Value Builder.
Resmed has a current Value Trend Rating of D (Negative). This VT Rating improved modestly in recent days from F previously. The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Resmed has a poor Appreciation Score of 23 but a neutral Power Rating of 55, leading to the Negative Value Trend Rating.
Recent Price Action
Resmed Inc (NYSE: RMD) stock declined modestly by -1.9% on 4/12/24. The stock closed at $185.86. However, below average trading volume at 67% of normal accompanied the decline. The stock has been strong relative to the market over the last nine months and is unchanged during the last week.
Be the first to comment